These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8592670)

  • 21. Jet and ultrasonic nebulization of single chain urokinase plasminogen activator (scu-PA).
    Münster AM; Bendstrup E; Jensen JI; Gram J
    J Aerosol Med; 2000; 13(4):325-33. PubMed ID: 11262439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of glucocorticoids by jet nebulization: aerosol characteristics and output.
    Leflein J; Brown E; Hill M; Kelly HW; Loffert DT; Nelson HS; Szefler SJ
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):944-9. PubMed ID: 7751514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some factors associated with the ultrasonic nebulization of proteins.
    Niven RW; Ip AY; Mittelman S; Prestrelski SJ; Arakawa T
    Pharm Res; 1995 Jan; 12(1):53-9. PubMed ID: 7724488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein.
    Steckel H; Eskandar F; Witthohn K
    Eur J Pharm Biopharm; 2003 Jul; 56(1):11-21. PubMed ID: 12837476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhalation Properties and Stability of Nebulized Naked siRNA Solution for Pulmonary Therapy.
    Tahara K; Hashimoto W; Takeuchi H
    Chem Pharm Bull (Tokyo); 2016; 64(1):63-7. PubMed ID: 26726746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaporation of aqueous aerosols produced by jet nebulizers: effects on particle size and concentration of solution in the droplets.
    Phipps PR; Gonda I
    J Aerosol Med; 1994; 7(3):239-58. PubMed ID: 10150482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers.
    Najlah M; Vali A; Taylor M; Arafat BT; Ahmed W; Phoenix DA; Taylor KM; Elhissi A
    Int J Pharm; 2013 Nov; 456(2):520-7. PubMed ID: 23973409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of shear and extensional viscosities on atomization of Newtonian and non-Newtonian fluids in ultrasonic inhaler.
    Broniarz-Press L; Sosnowski TR; Matuszak M; Ochowiak M; Jabłczyńska K
    Int J Pharm; 2015 May; 485(1-2):41-9. PubMed ID: 25735665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.
    Zarogoulidis P; Petridis D; Ritzoulis C; Li Q; Huang H; Ning Y; Darwiche K; Freitag L; Zarogoulidis K
    Int J Pharm; 2013 Dec; 458(1):39-47. PubMed ID: 24140545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization.
    Ip AY; Arakawa T; Silvers H; Ransone CM; Niven RW
    J Pharm Sci; 1995 Oct; 84(10):1210-4. PubMed ID: 8801336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.
    Dailey LA; Schmehl T; Gessler T; Wittmar M; Grimminger F; Seeger W; Kissel T
    J Control Release; 2003 Jan; 86(1):131-44. PubMed ID: 12490379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The analysis of pneumatic atomization of Newtonian and non-Newtonian fluids for different medical nebulizers.
    Ochowiak M; Matuszak M; Włodarczak S
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1999-2010. PubMed ID: 28737431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified polyethylenimines as non-viral gene delivery systems for aerosol gene therapy: investigations of the complex structure and stability during air-jet and ultrasonic nebulization.
    Kleemann E; Dailey LA; Abdelhady HG; Gessler T; Schmehl T; Roberts CJ; Davies MC; Seeger W; Kissel T
    J Control Release; 2004 Dec; 100(3):437-50. PubMed ID: 15567508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of nebulized buparvaquone nanosuspensions--effect of nebulization technology.
    Hernández-Trejo N; Kayser O; Steckel H; Müller RH
    J Drug Target; 2005; 13(8-9):499-507. PubMed ID: 16332575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of magnetizable aerosols.
    Baumann R; Glöckl G; Nagel S; Weitschies W
    Eur J Pharm Sci; 2012 Apr; 45(5):693-7. PubMed ID: 22306649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity.
    Marks LB; Notter RH; Oberdorster G; McBride JT
    Pediatr Res; 1983 Sep; 17(9):742-7. PubMed ID: 6622110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical properties of aerosolized immunoglobulin for inhalation therapy.
    Rimensberger PC; Roth C
    J Aerosol Med; 1995; 8(3):255-62. PubMed ID: 10155651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.